Remove Biopharma Remove Pharma Remove Pharmaceutical manufacturing Remove Prospecting
article thumbnail

AmerisourceBergen agrees to acquire PharmaLex for $1.29bn

Pharmaceutical Technology

The company provides strategic assistance and regulatory support to biopharma firms across the lifecycle of the product. The PharmaLex takeover will build upon the current European presence of AmerisourceBergen in pharmaceutical supply and biopharma manufacturer services expertise.